Cadrenal increases equity plan share limit
Plans to amend its equity incentive plan to increase the maximum authorized share count to 1 million, pending stockholder approval. Market Alpha ratings updated with new analyst forecasts and corporate development summary.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed